Tesla To $230? Plus Canaccord Genuity Cuts PT On T2 Biosystems By 80%
Wells Fargo cut the price target onTesla, Inc.from $280 to $230. Wells Fargo analyst Colin Langan maintained an Equal-Weight rating on the stock. Tesla shares fell 0.4% to $220.85 in pre-market trading.Canaccord Genuity cut the price target forT2 Biosystems, Inc.from $12.5 to $2.5. Canaccord Genuity analyst Kyle Mikson downgraded the stock from Buy to Hold. T2 Biosystems shares fell 4.7% to $2.43 in pre-market trading.Keybanc cut the price target onMSC Industrial Direct Co., Inc.from $100 to $93